Whole-exome sequencing identifies prognostic mutational signatures in gastric cancer

BACKGROUND: Gastric cancer (GC) is a heterogeneous disease, and is a leading cause of cancer deaths in Eastern Asia. Genomic analysis, such as whole-exome sequencing (WES), can help identify key genetic alterations leading to the malignancy and diversity of GC, and may help identify new drug targets...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Transl Med
Autors principals: Zhu, Zhenxin, Fu, Hongbing, Wang, Shengzhou, Yu, Xinxin, You, Qing, Shi, Mengyao, Dai, Chun, Wang, Guan, Cha, Wei, Wang, Weimin
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7729362/
https://ncbi.nlm.nih.gov/pubmed/33313229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-6620
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars